PeptiDream Inc. (TYO:4587)
Japan · Delayed Price · Currency is JPY 1,196.50
+45.50 (3.95%)
At close: Mar 27, 2026
PeptiDream Market Cap
PeptiDream has a market cap or net worth of 154.6 billion as of March 27, 2026. Its market cap has decreased by -41.81% in one year.
Market Cap
154.60B
Enterprise Value
143.63B
Revenue
18.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,196.50
Market Cap Chart
Since June 11, 2013, PeptiDream's market cap has increased from 74.10B to 154.60B, an increase of 108.65%. That is a compound annual growth rate of 5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 154.60B | -27.77% |
| Dec 30, 2025 | 214.04B | -37.55% |
| Dec 30, 2024 | 342.76B | 77.91% |
| Dec 29, 2023 | 192.66B | -28.55% |
| Dec 30, 2022 | 269.66B | -18.39% |
| Dec 30, 2021 | 330.41B | -49.84% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GNI Group | 169.24B |
| SanBio Company | 143.27B |
| Takara Bio | 138.24B |
| Nxera Pharma | 78.73B |
| Oncolys BioPharma | 66.86B |
| Cuorips | 58.10B |
| Healios K.K. | 49.55B |
| Stella Pharma | 28.59B |